{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,6]],"date-time":"2026-10-06T14:03:53Z","timestamp":1791295433429,"version":"4.1.0"},"reference-count":184,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2024,12,1]],"date-time":"2024-12-01T00:00:00Z","timestamp":1733011200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2024,12,1]],"date-time":"2024-12-01T00:00:00Z","timestamp":1733011200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2024,10,26]],"date-time":"2024-10-26T00:00:00Z","timestamp":1729900800000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0\/"}],"funder":[{"DOI":"10.13039\/501100008233","name":"School of Medicine, Shanghai Jiao Tong University","doi-asserted-by":"publisher","award":["2023-rbcxjj-001"],"award-info":[{"award-number":["2023-rbcxjj-001"]}],"id":[{"id":"10.13039\/501100008233","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100008233","name":"School of Medicine, Shanghai Jiao Tong University","doi-asserted-by":"publisher","award":["RJPY-LX-004"],"award-info":[{"award-number":["RJPY-LX-004"]}],"id":[{"id":"10.13039\/501100008233","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100020737","name":"Renji Hospital","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100020737","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Cytokine &amp; Growth Factor Reviews"],"published-print":{"date-parts":[[2024,12]]},"DOI":"10.1016\/j.cytogfr.2024.10.003","type":"journal-article","created":{"date-parts":[[2024,10,18]],"date-time":"2024-10-18T09:24:38Z","timestamp":1729243478000},"page":"156-167","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":18,"special_numbering":"C","title":["Unraveling the intricacies of neutrophil extracellular traps in inflammatory bowel disease: Pathways, biomarkers, and promising therapies"],"prefix":"10.1016","volume":"80","author":[{"given":"Yilin","family":"Wu","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-7206-1847","authenticated-orcid":false,"given":"Jun","family":"Shen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"issue":"10080","key":"10.1016\/j.cytogfr.2024.10.003_bib1","doi-asserted-by":"crossref","first-page":"1756","DOI":"10.1016\/S0140-6736(16)32126-2","article-title":"Ulcerative colitis","volume":"389","author":"Ungaro","year":"2017","journal-title":"Lancet"},{"issue":"11","key":"10.1016\/j.cytogfr.2024.10.003_bib2","doi-asserted-by":"crossref","first-page":"1017","DOI":"10.1038\/ni.2987","article-title":"Neutrophils sense microbe size and selectively release neutrophil extracellular traps in response to large pathogens","volume":"15","author":"Branzk","year":"2014","journal-title":"Nat. Immunol."},{"issue":"5663","key":"10.1016\/j.cytogfr.2024.10.003_bib3","doi-asserted-by":"crossref","first-page":"1532","DOI":"10.1126\/science.1092385","article-title":"Neutrophil extracellular traps kill bacteria","volume":"303","author":"Brinkmann","year":"2004","journal-title":"Science"},{"issue":"11","key":"10.1016\/j.cytogfr.2024.10.003_bib4","doi-asserted-by":"crossref","first-page":"3334","DOI":"10.1111\/febs.15589","article-title":"NET formation - mechanisms and how they relate to other cell death pathways","volume":"288","author":"Rosazza","year":"2021","journal-title":"Febs J."},{"issue":"4","key":"10.1016\/j.cytogfr.2024.10.003_bib5","doi-asserted-by":"crossref","first-page":"738","DOI":"10.1160\/TH15-09-0710","article-title":"Phosphotidylserine exposure and neutrophil extracellular traps enhance procoagulant activity in patients with inflammatory bowel disease","volume":"115","author":"He","year":"2016","journal-title":"Thromb. Haemost."},{"issue":"5","key":"10.1016\/j.cytogfr.2024.10.003_bib6","doi-asserted-by":"crossref","first-page":"1192","DOI":"10.3748\/wjg.v20.i5.1192","article-title":"Role of the gut microbiota in inflammatory bowel disease pathogenesis: what have we learnt in the past 10 years?","volume":"20","author":"Hold","year":"2014","journal-title":"World J. Gastroenterol."},{"issue":"3","key":"10.1016\/j.cytogfr.2024.10.003_bib7","doi-asserted-by":"crossref","first-page":"279","DOI":"10.1038\/nm.4294","article-title":"An emerging role for neutrophil extracellular traps in noninfectious disease","volume":"23","author":"Jorch","year":"2017","journal-title":"Nat. Med"},{"issue":"5","key":"10.1016\/j.cytogfr.2024.10.003_bib8","doi-asserted-by":"crossref","DOI":"10.1038\/cddis.2017.52","article-title":"The role of extracellular histone in organ injury","volume":"8","author":"Silk","year":"2017","journal-title":"Cell Death Dis."},{"key":"10.1016\/j.cytogfr.2024.10.003_bib9","doi-asserted-by":"crossref","first-page":"1849","DOI":"10.3389\/fimmu.2017.01849","article-title":"Alkaline pH Promotes NADPH Oxidase-Independent Neutrophil Extracellular Trap Formation: A Matter of Mitochondrial Reactive Oxygen Species Generation and Citrullination and Cleavage of Histone","volume":"8","author":"Naffah de Souza","year":"2017","journal-title":"Front Immunol."},{"key":"10.1016\/j.cytogfr.2024.10.003_bib10","doi-asserted-by":"crossref","first-page":"359","DOI":"10.3389\/fimmu.2018.00359","article-title":"Hypertonic Saline Suppresses NADPH Oxidase-dependent neutrophil extracellular trap formation and promotes apoptosis","volume":"9","author":"Nadesalingam","year":"2018","journal-title":"Front Immunol."},{"issue":"6","key":"10.1016\/j.cytogfr.2024.10.003_bib11","doi-asserted-by":"crossref","first-page":"3119","DOI":"10.3390\/ijms22063119","article-title":"Cross-talk among polymorphonuclear neutrophils, immune, and non-immune cells via released cytokines, granule proteins, microvesicles, and neutrophil extracellular trap formation: a novel concept of biology and pathobiology for neutrophils","volume":"22","author":"Tsai","year":"2021","journal-title":"Int. J. Mol. Sci."},{"issue":"6","key":"10.1016\/j.cytogfr.2024.10.003_bib12","doi-asserted-by":"crossref","first-page":"2689","DOI":"10.4049\/jimmunol.1201719","article-title":"Neutrophil extracellular traps: double-edged swords of innate immunity","volume":"189","author":"Kaplan","year":"2012","journal-title":"J. Immunol."},{"key":"10.1016\/j.cytogfr.2024.10.003_bib13","doi-asserted-by":"crossref","DOI":"10.7554\/eLife.24437","article-title":"Diverse stimuli engage different neutrophil extracellular trap pathways","volume":"6","author":"Kenny","year":"2017","journal-title":"Elife"},{"issue":"4","key":"10.1016\/j.cytogfr.2024.10.003_bib14","doi-asserted-by":"crossref","first-page":"841","DOI":"10.1189\/jlb.1211601","article-title":"Requirements for NADPH oxidase and myeloperoxidase in neutrophil extracellular trap formation differ depending on the stimulus","volume":"92","author":"Parker","year":"2012","journal-title":"J. Leukoc. Biol."},{"issue":"9","key":"10.1016\/j.cytogfr.2024.10.003_bib15","doi-asserted-by":"crossref","first-page":"2817","DOI":"10.1073\/pnas.1414055112","article-title":"SK3 channel and mitochondrial ROS mediate NADPH oxidase-independent NETosis induced by calcium influx","volume":"112","author":"Douda","year":"2015","journal-title":"Proc. Natl. Acad. Sci. USA"},{"issue":"2","key":"10.1016\/j.cytogfr.2024.10.003_bib16","doi-asserted-by":"crossref","first-page":"205","DOI":"10.1083\/jcb.200806072","article-title":"Histone hypercitrullination mediates chromatin decondensation and neutrophil extracellular trap formation","volume":"184","author":"Wang","year":"2009","journal-title":"J. Cell Biol."},{"key":"10.1016\/j.cytogfr.2024.10.003_bib17","doi-asserted-by":"crossref","first-page":"2481","DOI":"10.3389\/fimmu.2019.02481","article-title":"Citrullination licenses calpain to decondense nuclei in neutrophil extracellular trap formation","volume":"10","author":"G\u00f6\u00dfwein","year":"2019","journal-title":"Front Immunol."},{"issue":"4","key":"10.1016\/j.cytogfr.2024.10.003_bib18","doi-asserted-by":"crossref","first-page":"463","DOI":"10.1038\/nm1565","article-title":"Platelet TLR4 activates neutrophil extracellular traps to ensnare bacteria in septic blood","volume":"13","author":"Clark","year":"2007","journal-title":"Nat. Med"},{"key":"10.1016\/j.cytogfr.2024.10.003_bib19","doi-asserted-by":"crossref","first-page":"2036","DOI":"10.3389\/fimmu.2018.02036","article-title":"Physiological Stimuli Induce PAD4-Dependent, ROS-Independent NETosis, with early and late events controlled by discrete signaling pathways","volume":"9","author":"Tatsiy","year":"2018","journal-title":"Front Immunol."},{"issue":"16","key":"10.1016\/j.cytogfr.2024.10.003_bib20","doi-asserted-by":"crossref","first-page":"2784","DOI":"10.1182\/blood-2013-04-457671","article-title":"NETosis: how vital is it?","volume":"122","author":"Yipp","year":"2013","journal-title":"Blood"},{"issue":"11","key":"10.1016\/j.cytogfr.2024.10.003_bib21","doi-asserted-by":"crossref","first-page":"1438","DOI":"10.1038\/cdd.2009.96","article-title":"Viable neutrophils release mitochondrial DNA to form neutrophil extracellular traps","volume":"16","author":"Yousefi","year":"2009","journal-title":"Cell Death Differ."},{"issue":"9","key":"10.1016\/j.cytogfr.2024.10.003_bib22","doi-asserted-by":"crossref","first-page":"949","DOI":"10.1038\/nm.1855","article-title":"Catapult-like release of mitochondrial DNA by eosinophils contributes to antibacterial defense","volume":"14","author":"Yousefi","year":"2008","journal-title":"Nat. Med"},{"issue":"11","key":"10.1016\/j.cytogfr.2024.10.003_bib23","doi-asserted-by":"crossref","first-page":"5314","DOI":"10.4049\/jimmunol.1303418","article-title":"NADPH oxidase-independent formation of extracellular DNA traps by basophils","volume":"192","author":"Morshed","year":"2014","journal-title":"J. Immunol."},{"issue":"5","key":"10.1016\/j.cytogfr.2024.10.003_bib24","doi-asserted-by":"crossref","first-page":"2647","DOI":"10.4049\/jimmunol.1300436","article-title":"Macrophage clearance of neutrophil extracellular traps is a silent process","volume":"191","author":"Farrera","year":"2013","journal-title":"J. Immunol."},{"issue":"5","key":"10.1016\/j.cytogfr.2024.10.003_bib25","doi-asserted-by":"crossref","DOI":"10.3390\/ijms24054896","article-title":"Molecular mechanisms of neutrophil extracellular trap (nets) degradation","volume":"24","author":"Demkow","year":"2023","journal-title":"Int J. Mol. Sci."},{"issue":"21","key":"10.1016\/j.cytogfr.2024.10.003_bib26","doi-asserted-by":"crossref","first-page":"9813","DOI":"10.1073\/pnas.0909927107","article-title":"Impairment of neutrophil extracellular trap degradation is associated with lupus nephritis","volume":"107","author":"Hakkim","year":"2010","journal-title":"Proc. Natl. Acad. Sci. USA"},{"issue":"6","key":"10.1016\/j.cytogfr.2024.10.003_bib27","doi-asserted-by":"crossref","first-page":"944","DOI":"10.1136\/annrheumdis-2017-212617","article-title":"Differential ubiquitination in NETs regulates macrophage responses in systemic lupus erythematosus","volume":"77","author":"Barrera-Vargas","year":"2018","journal-title":"Ann. Rheum. Dis."},{"issue":"15","key":"10.1016\/j.cytogfr.2024.10.003_bib28","doi-asserted-by":"crossref","DOI":"10.3390\/cells11152463","article-title":"LL-37, a Multi-faceted amphipathic peptide involved in netosis","volume":"11","author":"Radic","year":"2022","journal-title":"Cells"},{"key":"10.1016\/j.cytogfr.2024.10.003_bib29","article-title":"NETosis and neutrophil extracellular traps in COVID-19: immunothrombosis and beyond","volume":"13","author":"Zhu","year":"2022","journal-title":"Front. Immunol."},{"key":"10.1016\/j.cytogfr.2024.10.003_bib30","doi-asserted-by":"crossref","DOI":"10.1016\/j.phrs.2021.105779","article-title":"Neutrophil extracellular traps in inflammatory bowel diseases: Implications in pathogenesis and therapeutic targets","volume":"171","author":"Dos Santos Ramos","year":"2021","journal-title":"Pharm. Res"},{"issue":"1","key":"10.1016\/j.cytogfr.2024.10.003_bib31","doi-asserted-by":"crossref","first-page":"109","DOI":"10.1007\/s12016-012-8349-4","article-title":"Presence of anti-proteinase 3 antineutrophil cytoplasmic antibodies (anti-PR3 ANCA) as serologic markers in inflammatory bowel disease","volume":"45","author":"Arias-Loste","year":"2013","journal-title":"Clin. Rev. Allergy Immunol."},{"issue":"12","key":"10.1016\/j.cytogfr.2024.10.003_bib32","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0225051","article-title":"The role of endothelial MERTK during the inflammatory response in lungs","volume":"14","author":"Li","year":"2019","journal-title":"PLOS ONE"},{"issue":"2","key":"10.1016\/j.cytogfr.2024.10.003_bib33","doi-asserted-by":"crossref","first-page":"240","DOI":"10.1093\/ecco-jcc\/jjz132","article-title":"Neutrophil extracellular traps induce intestinal damage and thrombotic tendency in inflammatory bowel disease","volume":"14","author":"Li","year":"2019","journal-title":"J. Crohn'S. Colitis"},{"issue":"1","key":"10.1016\/j.cytogfr.2024.10.003_bib34","doi-asserted-by":"crossref","first-page":"115","DOI":"10.5217\/ir.2019.00125","article-title":"Proinflammatory cytokines in irritable bowel syndrome: a comparison with inflammatory bowel disease","volume":"18","author":"Mitselou","year":"2020","journal-title":"Intest Res"},{"issue":"7","key":"10.1016\/j.cytogfr.2024.10.003_bib35","doi-asserted-by":"crossref","first-page":"815","DOI":"10.1038\/nm.3887","article-title":"Diabetes primes neutrophils to undergo NETosis, which impairs wound healing","volume":"21","author":"Wong","year":"2015","journal-title":"Nat. Med"},{"issue":"4","key":"10.1016\/j.cytogfr.2024.10.003_bib36","doi-asserted-by":"crossref","first-page":"1061","DOI":"10.2337\/db15-0863","article-title":"NETosis Delays Diabetic Wound Healing in Mice and Humans","volume":"65","author":"Fadini","year":"2016","journal-title":"Diabetes"},{"issue":"8","key":"10.1016\/j.cytogfr.2024.10.003_bib37","doi-asserted-by":"crossref","DOI":"10.3390\/biom9080365","article-title":"Neutrophil extracellular trap formation: physiology, pathology, and pharmacology","volume":"9","author":"Ravindran","year":"2019","journal-title":"Biomolecules"},{"issue":"1","key":"10.1016\/j.cytogfr.2024.10.003_bib38","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1007\/s12328-017-0813-5","article-title":"Gut microbiota in the pathogenesis of inflammatory bowel disease","volume":"11","author":"Nishida","year":"2018","journal-title":"Clin. J. Gastroenterol."},{"issue":"6","key":"10.1016\/j.cytogfr.2024.10.003_bib39","doi-asserted-by":"crossref","first-page":"1052","DOI":"10.1136\/gutjnl-2016-313535","article-title":"CD177(+) neutrophils as functionally activated neutrophils negatively regulate IBD","volume":"67","author":"Zhou","year":"2018","journal-title":"Gut"},{"issue":"4","key":"10.1016\/j.cytogfr.2024.10.003_bib40","doi-asserted-by":"crossref","first-page":"354","DOI":"10.1038\/mi.2012.24","article-title":"The role of neutrophils during intestinal inflammation","volume":"5","author":"Fournier","year":"2012","journal-title":"Mucosal Immunol."},{"issue":"1","key":"10.1016\/j.cytogfr.2024.10.003_bib41","first-page":"56","article-title":"Antinucleosome antibodies and decreased deoxyribonuclease activity in sera of patients with systemic lupus erythematosus","volume":"12","author":"Sallai","year":"2005","journal-title":"Clin. Diagn. Lab Immunol."},{"issue":"1","key":"10.1016\/j.cytogfr.2024.10.003_bib42","doi-asserted-by":"crossref","first-page":"76","DOI":"10.1002\/1529-0131(200001)43:1<76::AID-ANR10>3.0.CO;2-I","article-title":"Presence of antinucleosome autoantibodies in a restricted set of connective tissue diseases: antinucleosome antibodies of the IgG3 subclass are markers of renal pathogenicity in systemic lupus erythematosus","volume":"43","author":"Amoura","year":"2000","journal-title":"Arthritis Rheum."},{"key":"10.1016\/j.cytogfr.2024.10.003_bib43","article-title":"Impaired deoxyribonuclease I activity in patients with inflammatory bowel diseases","volume":"2011","author":"Mal\u00ed\u010dkov\u00e1","year":"2011","journal-title":"Autoimmune Dis."},{"issue":"6917","key":"10.1016\/j.cytogfr.2024.10.003_bib44","doi-asserted-by":"crossref","first-page":"846","DOI":"10.1038\/nature01320","article-title":"Points of control in inflammation","volume":"420","author":"Nathan","year":"2002","journal-title":"Nature"},{"key":"10.1016\/j.cytogfr.2024.10.003_bib45","article-title":"Rules of Engagement: Epithelial-Microbe Interactions and Inflammatory Bowel Disease","volume":"8","author":"Jergens","year":"2021","journal-title":"Front Med (Lausanne)"},{"issue":"2","key":"10.1016\/j.cytogfr.2024.10.003_bib46","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0032366","article-title":"Neutrophil extracellular traps directly induce epithelial and endothelial cell death: a predominant role of histones","volume":"7","author":"Saffarzadeh","year":"2012","journal-title":"PLoS One"},{"issue":"7","key":"10.1016\/j.cytogfr.2024.10.003_bib47","doi-asserted-by":"crossref","first-page":"1556","DOI":"10.1097\/MIB.0b013e318281f54e","article-title":"The role of polymorphonuclear leukocyte trafficking in the perpetuation of inflammation during inflammatory bowel disease","volume":"19","author":"Brazil","year":"2013","journal-title":"Inflamm. Bowel Dis."},{"key":"10.1016\/j.cytogfr.2024.10.003_bib48","doi-asserted-by":"crossref","first-page":"111","DOI":"10.1146\/annurev.pathol.2.010506.091944","article-title":"Pathobiology of neutrophil transepithelial migration: implications in mediating epithelial injury","volume":"2","author":"Chin","year":"2007","journal-title":"Annu Rev. Pathol."},{"issue":"5","key":"10.1016\/j.cytogfr.2024.10.003_bib49","doi-asserted-by":"crossref","first-page":"783","DOI":"10.1093\/ibd\/izac256","article-title":"Histones of neutrophil extracellular traps directly disrupt the permeability and integrity of the intestinal epithelial barrier","volume":"29","author":"Lai","year":"2023","journal-title":"Inflamm. Bowel Dis."},{"key":"10.1016\/j.cytogfr.2024.10.003_bib50","doi-asserted-by":"crossref","DOI":"10.1155\/2015\/628157","article-title":"Intestinal permeability in inflammatory bowel disease: pathogenesis, clinical evaluation, and therapy of leaky gut","volume":"2015","author":"Michielan","year":"2015","journal-title":"Mediat. Inflamm."},{"issue":"5","key":"10.1016\/j.cytogfr.2024.10.003_bib51","doi-asserted-by":"crossref","first-page":"1891","DOI":"10.1128\/IAI.00050-12","article-title":"Afa\/Dr diffusely adhering Escherichia coli strain C1845 induces neutrophil extracellular traps that kill bacteria and damage human enterocyte-like cells","volume":"80","author":"Marin-Esteban","year":"2012","journal-title":"Infect. Immun."},{"issue":"11","key":"10.1016\/j.cytogfr.2024.10.003_bib52","doi-asserted-by":"crossref","first-page":"1245","DOI":"10.1038\/nm1109-1245","article-title":"Sepsis: the dark side of histones","volume":"15","author":"Chaput","year":"2009","journal-title":"Nat. Med"},{"issue":"6","key":"10.1016\/j.cytogfr.2024.10.003_bib53","doi-asserted-by":"crossref","first-page":"623","DOI":"10.1038\/nm.1959","article-title":"Netting neutrophils in autoimmune small-vessel vasculitis","volume":"15","author":"Kessenbrock","year":"2009","journal-title":"Nat. Med"},{"issue":"28","key":"10.1016\/j.cytogfr.2024.10.003_bib54","article-title":"Exosomes-transferred LINC00668 Contributes to Thrombosis by Promoting NETs Formation in Inflammatory Bowel Disease","volume":"10","author":"Zhang","year":"2023","journal-title":"Adv. Sci. (Weinh. )"},{"issue":"11-12","key":"10.1016\/j.cytogfr.2024.10.003_bib55","doi-asserted-by":"crossref","DOI":"10.1002\/prca.201700053","article-title":"The proteome of ulcerative colitis in colon biopsies from adults - optimized sample preparation and comparison with healthy controls","volume":"11","author":"Schniers","year":"2017","journal-title":"Proteom. Clin. Appl."},{"issue":"12","key":"10.1016\/j.cytogfr.2024.10.003_bib56","doi-asserted-by":"crossref","first-page":"1749","DOI":"10.1038\/labinvest.2012.141","article-title":"Lack of MMP10 exacerbates experimental colitis and promotes development of inflammation-associated colonic dysplasia","volume":"92","author":"Koller","year":"2012","journal-title":"Lab Invest"},{"issue":"1","key":"10.1016\/j.cytogfr.2024.10.003_bib57","doi-asserted-by":"crossref","first-page":"67","DOI":"10.1039\/C8MO00239H","article-title":"Degradation of the extracellular matrix is part of the pathology of ulcerative colitis","volume":"15","author":"Kirov","year":"2019","journal-title":"Mol. Omics"},{"issue":"36","key":"10.1016\/j.cytogfr.2024.10.003_bib58","doi-asserted-by":"crossref","first-page":"15880","DOI":"10.1073\/pnas.1005743107","article-title":"Extracellular DNA traps promote thrombosis","volume":"107","author":"Fuchs","year":"2010","journal-title":"Proc. Natl. Acad. Sci. USA"},{"issue":"3","key":"10.1016\/j.cytogfr.2024.10.003_bib59","doi-asserted-by":"crossref","first-page":"779","DOI":"10.1053\/j.gastro.2010.05.026","article-title":"Inflammatory bowel disease is a risk factor for recurrent venous thromboembolism","volume":"139","author":"Novacek","year":"2010","journal-title":"Gastroenterology"},{"issue":"1","key":"10.1016\/j.cytogfr.2024.10.003_bib60","doi-asserted-by":"crossref","DOI":"10.1096\/fj.202301780R","article-title":"DNase aggravates intestinal microvascular injury in IBD patients by releasing NET-related proteins","volume":"38","author":"Shao","year":"2024","journal-title":"Faseb J."},{"issue":"6","key":"10.1016\/j.cytogfr.2024.10.003_bib61","doi-asserted-by":"crossref","first-page":"2774","DOI":"10.2353\/ajpath.2010.100205","article-title":"Interleukin-1beta mediates the extra-intestinal thrombosis associated with experimental colitis","volume":"177","author":"Yoshida","year":"2010","journal-title":"Am. J. Pathol."},{"issue":"11","key":"10.1016\/j.cytogfr.2024.10.003_bib62","doi-asserted-by":"crossref","first-page":"2217","DOI":"10.1002\/ibd.21593","article-title":"Role of tumor necrosis factor-\u03b1 in the extraintestinal thrombosis associated with colonic inflammation","volume":"17","author":"Yoshida","year":"2011","journal-title":"Inflamm. Bowel Dis."},{"issue":"1","key":"10.1016\/j.cytogfr.2024.10.003_bib63","doi-asserted-by":"crossref","first-page":"173","DOI":"10.1016\/j.ajpath.2013.03.014","article-title":"Interleukin-6 mediates the platelet abnormalities and thrombogenesis associated with experimental colitis","volume":"183","author":"Senchenkova","year":"2013","journal-title":"Am. J. Pathol."},{"issue":"6","key":"10.1016\/j.cytogfr.2024.10.003_bib64","doi-asserted-by":"crossref","first-page":"1289","DOI":"10.1160\/TH14-08-0669","article-title":"DNA, histones and neutrophil extracellular traps exert anti-fibrinolytic effects in a plasma environment","volume":"113","author":"Varj\u00fa","year":"2015","journal-title":"Thromb. Haemost."},{"issue":"6","key":"10.1016\/j.cytogfr.2024.10.003_bib65","doi-asserted-by":"crossref","first-page":"772","DOI":"10.1093\/ecco-jcc\/jjy215","article-title":"Neutrophil extracellular traps sustain inflammatory signals in ulcerative colitis","volume":"13","author":"Dinallo","year":"2019","journal-title":"J. Crohn'S. Colitis"},{"issue":"3","key":"10.1016\/j.cytogfr.2024.10.003_bib66","doi-asserted-by":"crossref","first-page":"565","DOI":"10.1053\/j.gastro.2014.12.001","article-title":"Inhibition of plasmin protects against colitis in mice by suppressing matrix metalloproteinase 9-mediated cytokine release from myeloid cells","volume":"148","author":"Munakata","year":"2015","journal-title":"Gastroenterology"},{"key":"10.1016\/j.cytogfr.2024.10.003_bib67","doi-asserted-by":"crossref","first-page":"759","DOI":"10.1146\/annurev-immunol-020711-074937","article-title":"The microbiome in infectious disease and inflammation","volume":"30","author":"Honda","year":"2012","journal-title":"Annu Rev. Immunol."},{"issue":"3","key":"10.1016\/j.cytogfr.2024.10.003_bib68","doi-asserted-by":"crossref","first-page":"176","DOI":"10.1159\/000444066","article-title":"Physiological Role of Gut Microbiota for Maintaining Human Health","volume":"93","author":"Andoh","year":"2016","journal-title":"Digestion"},{"issue":"5","key":"10.1016\/j.cytogfr.2024.10.003_bib69","doi-asserted-by":"crossref","first-page":"495","DOI":"10.1007\/s00535-015-1064-1","article-title":"The microbiota in inflammatory bowel disease","volume":"50","author":"Sheehan","year":"2015","journal-title":"J. Gastroenterol."},{"issue":"1","key":"10.1016\/j.cytogfr.2024.10.003_bib70","doi-asserted-by":"crossref","first-page":"59","DOI":"10.1159\/000441768","article-title":"Reduced abundance of butyrate-producing bacteria species in the fecal microbial community in Crohn's disease","volume":"93","author":"Takahashi","year":"2016","journal-title":"Digestion"},{"issue":"4","key":"10.1016\/j.cytogfr.2024.10.003_bib71","doi-asserted-by":"crossref","first-page":"613","DOI":"10.1111\/jgh.12073","article-title":"Decreased abundance of Faecalibacterium prausnitzii in the gut microbiota of Crohn's disease","volume":"28","author":"Fujimoto","year":"2013","journal-title":"J. Gastroenterol. Hepatol."},{"issue":"2","key":"10.1016\/j.cytogfr.2024.10.003_bib72","doi-asserted-by":"crossref","first-page":"151","DOI":"10.1111\/apt.12365","article-title":"Colonisation by Faecalibacterium prausnitzii and maintenance of clinical remission in patients with ulcerative colitis","volume":"38","author":"Varela","year":"2013","journal-title":"Aliment Pharm. Ther."},{"issue":"6","key":"10.1016\/j.cytogfr.2024.10.003_bib73","doi-asserted-by":"crossref","first-page":"417","DOI":"10.1016\/j.chom.2008.05.001","article-title":"Metagenomic approaches for defining the pathogenesis of inflammatory bowel diseases","volume":"3","author":"Peterson","year":"2008","journal-title":"Cell Host Microbe"},{"issue":"4","key":"10.1016\/j.cytogfr.2024.10.003_bib74","doi-asserted-by":"crossref","first-page":"223","DOI":"10.1038\/s41575-019-0258-z","article-title":"Gut microbiota-derived metabolites as key actors in inflammatory bowel disease","volume":"17","author":"Lavelle","year":"2020","journal-title":"Nat. Rev. Gastroenterol. Hepatol."},{"issue":"2","key":"10.1016\/j.cytogfr.2024.10.003_bib75","doi-asserted-by":"crossref","first-page":"107","DOI":"10.1111\/j.1574-6941.2002.tb00942.x","article-title":"Sulfate-reducing bacteria in human feces and their association with inflammatory bowel diseases","volume":"40","author":"Loubinoux","year":"2002","journal-title":"FEMS Microbiol Ecol."},{"issue":"2","key":"10.1016\/j.cytogfr.2024.10.003_bib76","doi-asserted-by":"crossref","first-page":"147","DOI":"10.1111\/j.1574-6941.2000.tb00764.x","article-title":"Screening of sulfate-reducing bacteria in colonoscopy samples from healthy and colitic human gut mucosa","volume":"34","author":"Zinkevich","year":"2000","journal-title":"FEMS Microbiol Ecol."},{"issue":"11","key":"10.1016\/j.cytogfr.2024.10.003_bib77","doi-asserted-by":"crossref","first-page":"1530","DOI":"10.1007\/DCR.0b013e3181f1e620","article-title":"Desulfovibrio bacterial species are increased in ulcerative colitis","volume":"53","author":"Rowan","year":"2010","journal-title":"Dis. Colon Rectum"},{"issue":"1","key":"10.1016\/j.cytogfr.2024.10.003_bib78","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1007\/s00535-016-1242-9","article-title":"Microbiota metabolite short chain fatty acids, GPCR, and inflammatory bowel diseases","volume":"52","author":"Sun","year":"2017","journal-title":"J. Gastroenterol."},{"issue":"2","key":"10.1016\/j.cytogfr.2024.10.003_bib79","doi-asserted-by":"crossref","first-page":"546","DOI":"10.1021\/pr060470d","article-title":"Rapid and noninvasive metabonomic characterization of inflammatory bowel disease","volume":"6","author":"Marchesi","year":"2007","journal-title":"J. Proteome Res"},{"issue":"8","key":"10.1016\/j.cytogfr.2024.10.003_bib80","doi-asserted-by":"crossref","first-page":"1275","DOI":"10.1136\/gutjnl-2013-304833","article-title":"A decrease of the butyrate-producing species Roseburia hominis and Faecalibacterium prausnitzii defines dysbiosis in patients with ulcerative colitis","volume":"63","author":"Machiels","year":"2014","journal-title":"Gut"},{"issue":"1","key":"10.1016\/j.cytogfr.2024.10.003_bib81","doi-asserted-by":"crossref","first-page":"1968257","DOI":"10.1080\/19490976.2021.1968257","article-title":"Microbiota metabolite butyrate constrains neutrophil functions and ameliorates mucosal inflammation in inflammatory bowel disease","volume":"13","author":"Li","year":"2021","journal-title":"Gut Microbes"},{"issue":"7461","key":"10.1016\/j.cytogfr.2024.10.003_bib82","doi-asserted-by":"crossref","first-page":"232","DOI":"10.1038\/nature12331","article-title":"Treg induction by a rationally selected mixture of Clostridia strains from the human microbiota","volume":"500","author":"Atarashi","year":"2013","journal-title":"Nature"},{"issue":"9","key":"10.1016\/j.cytogfr.2024.10.003_bib83","doi-asserted-by":"crossref","first-page":"1853","DOI":"10.1084\/jem.20100239","article-title":"PAD4 is essential for antibacterial innate immunity mediated by neutrophil extracellular traps","volume":"207","author":"Li","year":"2010","journal-title":"J. Exp. Med"},{"issue":"Pt B)","key":"10.1016\/j.cytogfr.2024.10.003_bib84","article-title":"Targeted inhibition of FcRn reduces NET formation to ameliorate experimental ulcerative colitis by accelerating ANCA clearance","volume":"113","author":"Wen","year":"2022","journal-title":"Int Immunopharmacol."},{"issue":"10","key":"10.1016\/j.cytogfr.2024.10.003_bib85","doi-asserted-by":"crossref","first-page":"4595","DOI":"10.4049\/jimmunol.1403014","article-title":"FcRn: The Architect Behind the Immune and Nonimmune Functions of IgG and Albumin","volume":"194","author":"Pyzik","year":"2015","journal-title":"J. Immunol."},{"issue":"13","key":"10.1016\/j.cytogfr.2024.10.003_bib86","doi-asserted-by":"crossref","first-page":"4736","DOI":"10.1002\/cam4.3067","article-title":"The neonatal Fc receptor in cancer FcRn in cancer","volume":"9","author":"Cadena Castaneda","year":"2020","journal-title":"Cancer Med."},{"issue":"1","key":"10.1016\/j.cytogfr.2024.10.003_bib87","doi-asserted-by":"crossref","first-page":"3020","DOI":"10.1038\/s41467-019-10865-y","article-title":"Human cytomegalovirus evades antibody-mediated immunity through endoplasmic reticulum-associated degradation of the FcRn receptor","volume":"10","author":"Liu","year":"2019","journal-title":"Nat. Commun."},{"issue":"4","key":"10.1016\/j.cytogfr.2024.10.003_bib88","doi-asserted-by":"crossref","first-page":"1375","DOI":"10.1053\/j.gastro.2020.06.038","article-title":"IL1B Increases intestinal tight junction permeability by up-regulation of MIR200C-3p, Which Degrades Occludin mRNA","volume":"159","author":"Rawat","year":"2020","journal-title":"Gastroenterology"},{"issue":"5","key":"10.1016\/j.cytogfr.2024.10.003_bib89","doi-asserted-by":"crossref","DOI":"10.1016\/j.celrep.2020.107602","article-title":"Histones, DNA, and citrullination promote neutrophil extracellular trap inflammation by regulating the localization and activation of TLR4","volume":"31","author":"Tsourouktsoglou","year":"2020","journal-title":"Cell Rep."},{"issue":"5","key":"10.1016\/j.cytogfr.2024.10.003_bib90","doi-asserted-by":"crossref","first-page":"2434","DOI":"10.4049\/jimmunol.154.5.2434","article-title":"Mucosal imbalance of IL-1 and IL-1 receptor antagonist in inflammatory bowel disease. A novel mechanism of chronic intestinal inflammation","volume":"154","author":"Casini-Raggi","year":"1995","journal-title":"J. Immunol."},{"issue":"12","key":"10.1016\/j.cytogfr.2024.10.003_bib91","doi-asserted-by":"crossref","first-page":"3950","DOI":"10.4049\/jimmunol.1701643","article-title":"REDD1\/Autophagy pathway is associated with neutrophil-driven IL-1\u03b2 inflammatory response in active ulcerative colitis","volume":"200","author":"Angelidou","year":"2018","journal-title":"J. Immunol."},{"issue":"5","key":"10.1016\/j.cytogfr.2024.10.003_bib92","doi-asserted-by":"crossref","first-page":"289","DOI":"10.1038\/s41577-022-00792-3","article-title":"Death by TNF: a road to inflammation","volume":"23","author":"van Loo","year":"2023","journal-title":"Nat. Rev. Immunol."},{"issue":"1","key":"10.1016\/j.cytogfr.2024.10.003_bib93","doi-asserted-by":"crossref","DOI":"10.1038\/cddis.2012.201","article-title":"TNF can activate RIPK3 and cause programmed necrosis in the absence of RIPK1","volume":"4","author":"Moujalled","year":"2013","journal-title":"Cell Death Dis."},{"issue":"115","key":"10.1016\/j.cytogfr.2024.10.003_bib94","doi-asserted-by":"crossref","first-page":"re4","DOI":"10.1126\/scisignal.3115re4","article-title":"The role of the kinases RIP1 and RIP3 in TNF-induced necrosis","volume":"3","author":"Vandenabeele","year":"2010","journal-title":"Sci. Signal"},{"issue":"9","key":"10.1016\/j.cytogfr.2024.10.003_bib95","doi-asserted-by":"crossref","DOI":"10.3390\/cells11091386","article-title":"Properties and functions of fibroblasts and myofibroblasts in myocardial infarction","volume":"11","author":"Venugopal","year":"2022","journal-title":"Cells"},{"issue":"7","key":"10.1016\/j.cytogfr.2024.10.003_bib96","doi-asserted-by":"crossref","first-page":"1492","DOI":"10.3390\/biomedicines10071492","article-title":"The Current Status of Molecular Biomarkers for Inflammatory Bowel Disease","volume":"10","author":"Alghoul","year":"2022","journal-title":"Biomedicines"},{"issue":"9","key":"10.1016\/j.cytogfr.2024.10.003_bib97","doi-asserted-by":"crossref","first-page":"1324","DOI":"10.1038\/ajg.2015.233","article-title":"Selecting therapeutic targets in inflammatory bowel disease (STRIDE): determining therapeutic goals for treat-to-target","volume":"110","author":"Peyrin-Biroulet","year":"2015","journal-title":"Am. J. Gastroenterol."},{"issue":"5","key":"10.1016\/j.cytogfr.2024.10.003_bib98","doi-asserted-by":"crossref","first-page":"1570","DOI":"10.1053\/j.gastro.2020.12.031","article-title":"STRIDE-II: An update on the selecting therapeutic targets in inflammatory bowel disease (STRIDE) initiative of the international organization for the study of IBD (IOIBD): determining therapeutic goals for treat-to-target strategies in IBD","volume":"160","author":"Turner","year":"2021","journal-title":"Gastroenterology"},{"issue":"1","key":"10.1016\/j.cytogfr.2024.10.003_bib99","doi-asserted-by":"crossref","first-page":"30","DOI":"10.1159\/000527846","article-title":"Positioning and usefulness of biomarkers in inflammatory bowel disease","volume":"104","author":"Sakurai","year":"2022","journal-title":"Digestion"},{"issue":"11","key":"10.1016\/j.cytogfr.2024.10.003_bib100","doi-asserted-by":"crossref","first-page":"1503","DOI":"10.1093\/ecco-jcc\/jjaa110","article-title":"ECCO Position paper: harmonization of the approach to ulcerative colitis histopathology","volume":"14","author":"Magro","year":"2020","journal-title":"J. Crohns Colitis"},{"issue":"1","key":"10.1016\/j.cytogfr.2024.10.003_bib101","doi-asserted-by":"crossref","first-page":"162","DOI":"10.1111\/j.1572-0241.2007.01556.x","article-title":"Noninvasive markers in the assessment of intestinal inflammation in inflammatory bowel diseases: performance of fecal lactoferrin, calprotectin, and PMN-elastase, CRP, and clinical indices","volume":"103","author":"Langhorst","year":"2008","journal-title":"Am. J. Gastroenterol."},{"issue":"1","key":"10.1016\/j.cytogfr.2024.10.003_bib102","doi-asserted-by":"crossref","first-page":"26","DOI":"10.1097\/MPG.0b013e31822200cc","article-title":"Circulating microRNA is a biomarker of pediatric Crohn disease","volume":"53","author":"Zahm","year":"2011","journal-title":"J. Pedia Gastroenterol. Nutr."},{"issue":"4","key":"10.1016\/j.cytogfr.2024.10.003_bib103","doi-asserted-by":"crossref","first-page":"378","DOI":"10.1097\/MOG.0b013e328361f488","article-title":"Metabolomics: is it useful for inflammatory bowel diseases?","volume":"29","author":"Storr","year":"2013","journal-title":"Curr. Opin. Gastroenterol."},{"issue":"5","key":"10.1016\/j.cytogfr.2024.10.003_bib104","doi-asserted-by":"crossref","first-page":"498","DOI":"10.1111\/apt.12861","article-title":"Metabolomic analysis of breath volatile organic compounds reveals unique breathprints in children with inflammatory bowel disease: a pilot study","volume":"40","author":"Patel","year":"2014","journal-title":"Aliment Pharm. Ther."},{"issue":"5","key":"10.1016\/j.cytogfr.2024.10.003_bib105","doi-asserted-by":"crossref","first-page":"5659","DOI":"10.1007\/s11033-011-1373-2","article-title":"Comparative proteomics analysis of serum proteins in ulcerative colitis patients","volume":"39","author":"Li","year":"2012","journal-title":"Mol. Biol. Rep."},{"issue":"4","key":"10.1016\/j.cytogfr.2024.10.003_bib106","doi-asserted-by":"crossref","first-page":"616","DOI":"10.1002\/ibd.20652","article-title":"Applications of proteomics in the study of inflammatory bowel diseases: current status and future directions with available technologies","volume":"15","author":"Alex","year":"2009","journal-title":"Inflamm. Bowel Dis."},{"issue":"2","key":"10.1016\/j.cytogfr.2024.10.003_bib107","first-page":"141","article-title":"Biological markers of disease activity in inflammatory bowel diseases","volume":"18","author":"Szymanska","year":"2023","journal-title":"Prz. Gastroenterol."},{"key":"10.1016\/j.cytogfr.2024.10.003_bib108","doi-asserted-by":"crossref","DOI":"10.1177\/17562848231155987","article-title":"Pursuing neutrophils: systematic scoping review on blood-based biomarkers as predictors of treatment outcomes in inflammatory bowel disease","volume":"16","author":"Magalhaes","year":"2023","journal-title":"Ther. Adv. Gastroenterol."},{"issue":"Suppl 2","key":"10.1016\/j.cytogfr.2024.10.003_bib109","article-title":"The role of neutrophils in the pathogenesis of Crohn's disease","volume":"48","author":"Segal","year":"2018","journal-title":"Eur. J. Clin. Invest"},{"issue":"4","key":"10.1016\/j.cytogfr.2024.10.003_bib110","doi-asserted-by":"crossref","first-page":"915","DOI":"10.3390\/cells9040915","article-title":"Neutrophil Extracellular Traps (NETs) take the central stage in driving autoimmune responses","volume":"9","author":"Fousert","year":"2020","journal-title":"Cells"},{"issue":"9573","key":"10.1016\/j.cytogfr.2024.10.003_bib111","doi-asserted-by":"crossref","first-page":"1641","DOI":"10.1016\/S0140-6736(07)60751-X","article-title":"Inflammatory bowel disease: clinical aspects and established and evolving therapies","volume":"369","author":"Baumgart","year":"2007","journal-title":"Lancet"},{"issue":"2","key":"10.1016\/j.cytogfr.2024.10.003_bib112","doi-asserted-by":"crossref","first-page":"731","DOI":"10.1007\/s10787-023-01149-5","article-title":"Selective inhibition of peptidyl-arginine deiminase (PAD): can it control multiple inflammatory disorders as a promising therapeutic strategy?","volume":"31","author":"Padhy","year":"2023","journal-title":"Inflammopharmacology"},{"issue":"6","key":"10.1016\/j.cytogfr.2024.10.003_bib113","doi-asserted-by":"crossref","first-page":"1528","DOI":"10.1038\/s41423-020-0381-3","article-title":"Therapeutic ACPA inhibits NET formation: a potential therapy for neutrophil-mediated inflammatory diseases","volume":"18","author":"Chirivi","year":"2021","journal-title":"Cell. Mol. Immunol."},{"issue":"26","key":"10.1016\/j.cytogfr.2024.10.003_bib114","doi-asserted-by":"crossref","DOI":"10.1126\/sciimmunol.aar6689","article-title":"Gasdermin D plays a vital role in the generation of neutrophil extracellular traps","volume":"3","author":"Sollberger","year":"2018","journal-title":"Sci. Immunol."},{"issue":"2","key":"10.1016\/j.cytogfr.2024.10.003_bib115","doi-asserted-by":"crossref","DOI":"10.1136\/bmjopen-2018-023765","article-title":"Trial summary and protocol for a phase II randomised placebo-controlled double-blinded trial of Interleukin 1 blockade in Acute Severe Colitis: the IASO trial","volume":"9","author":"Thomas","year":"2019","journal-title":"BMJ Open"},{"issue":"6","key":"10.1016\/j.cytogfr.2024.10.003_bib116","doi-asserted-by":"crossref","first-page":"1087","DOI":"10.1016\/j.kint.2018.08.035","article-title":"Extracellular traps in kidney disease","volume":"94","author":"Nakazawa","year":"2018","journal-title":"Kidney Int"},{"issue":"5","key":"10.1016\/j.cytogfr.2024.10.003_bib117","doi-asserted-by":"crossref","first-page":"511","DOI":"10.1038\/nm.3547","article-title":"Aggregated neutrophil extracellular traps limit inflammation by degrading cytokines and chemokines","volume":"20","author":"Schauer","year":"2014","journal-title":"Nat. Med"},{"issue":"6","key":"10.1016\/j.cytogfr.2024.10.003_bib118","doi-asserted-by":"crossref","first-page":"1257","DOI":"10.1016\/j.jcmgh.2022.09.002","article-title":"Neutrophil-epithelial crosstalk during intestinal inflammation","volume":"14","author":"Kang","year":"2022","journal-title":"Cell Mol. Gastroenterol. Hepatol."},{"issue":"4","key":"10.1016\/j.cytogfr.2024.10.003_bib119","doi-asserted-by":"crossref","first-page":"206","DOI":"10.1038\/nrgastro.2017.183","article-title":"Neutrophils and neutrophil extracellular traps in the liver and gastrointestinal system","volume":"15","author":"Honda","year":"2018","journal-title":"Nat. Rev. Gastroenterol. Hepatol."},{"key":"10.1016\/j.cytogfr.2024.10.003_bib120","doi-asserted-by":"crossref","first-page":"236","DOI":"10.3389\/fimmu.2016.00236","article-title":"The Emerging Role of NETs in Venous Thrombosis and Immunothrombosis","volume":"7","author":"Kimball","year":"2016","journal-title":"Front Immunol."},{"issue":"32","key":"10.1016\/j.cytogfr.2024.10.003_bib121","doi-asserted-by":"crossref","first-page":"13076","DOI":"10.1073\/pnas.1200419109","article-title":"Cancers predispose neutrophils to release extracellular DNA traps that contribute to cancer-associated thrombosis","volume":"109","author":"Demers","year":"2012","journal-title":"Proc. Natl. Acad. Sci. USA"},{"issue":"1-2","key":"10.1016\/j.cytogfr.2024.10.003_bib122","doi-asserted-by":"crossref","first-page":"90","DOI":"10.1159\/000442934","article-title":"ASCA, ANCA, ALCA and many more: are they useful in the diagnosis of inflammatory bowel disease?","volume":"34","author":"Zhou","year":"2016","journal-title":"Dig. Dis."},{"issue":"4","key":"10.1016\/j.cytogfr.2024.10.003_bib123","doi-asserted-by":"crossref","first-page":"253","DOI":"10.1038\/s41573-019-0054-z","article-title":"Neutrophils as emerging therapeutic targets","volume":"19","author":"N\u00e9meth","year":"2020","journal-title":"Nat. Rev. Drug Discov."},{"issue":"12","key":"10.1016\/j.cytogfr.2024.10.003_bib124","doi-asserted-by":"crossref","first-page":"982","DOI":"10.1016\/j.crohns.2013.09.016","article-title":"European evidence based consensus for endoscopy in inflammatory bowel disease","volume":"7","author":"Annese","year":"2013","journal-title":"J. Crohns Colitis"},{"key":"10.1016\/j.cytogfr.2024.10.003_bib125","doi-asserted-by":"crossref","first-page":"91","DOI":"10.1016\/j.semcancer.2021.07.011","article-title":"Neutrophil extracellular traps in cancer","volume":"79","author":"Cristinziano","year":"2022","journal-title":"Semin Cancer Biol."},{"key":"10.1016\/j.cytogfr.2024.10.003_bib126","doi-asserted-by":"crossref","DOI":"10.1016\/j.pharmthera.2022.108328","article-title":"Neutrophil extracellular traps: a novel target for the treatment of stroke","volume":"241","author":"Zhao","year":"2023","journal-title":"Pharm. Ther."},{"issue":"14","key":"10.1016\/j.cytogfr.2024.10.003_bib127","doi-asserted-by":"crossref","first-page":"1711","DOI":"10.1089\/ars.2012.4530","article-title":"Inflammatory bowel disease: mechanisms, redox considerations, and therapeutic targets","volume":"19","author":"Biasi","year":"2013","journal-title":"Antioxid. Redox Signal"},{"issue":"26","key":"10.1016\/j.cytogfr.2024.10.003_bib128","doi-asserted-by":"crossref","first-page":"3712","DOI":"10.3748\/wjg.v26.i26.3712","article-title":"Functional gastrointestinal disorders in inflammatory bowel disease: Time for a paradigm shift?","volume":"26","author":"Vasant","year":"2020","journal-title":"World J. Gastroenterol."},{"issue":"16","key":"10.1016\/j.cytogfr.2024.10.003_bib129","doi-asserted-by":"crossref","first-page":"1828","DOI":"10.3748\/wjg.v27.i16.1828","article-title":"Surrogate markers of mucosal healing in inflammatory bowel disease: A systematic review","volume":"27","author":"State","year":"2021","journal-title":"World J. Gastroenterol."},{"issue":"5","key":"10.1016\/j.cytogfr.2024.10.003_bib130","doi-asserted-by":"crossref","first-page":"1275","DOI":"10.1053\/j.gastro.2015.07.003","article-title":"Biomarkers of inflammation in inflammatory bowel disease","volume":"149","author":"Sands","year":"2015","journal-title":"Gastroenterology"},{"key":"10.1016\/j.cytogfr.2024.10.003_bib131","doi-asserted-by":"crossref","first-page":"6517549","DOI":"10.1155\/2019\/6517549","article-title":"Correlation between serological biomarkers and disease activity in patients with inflammatory bowel disease","volume":"2019","author":"Xu","year":"2019","journal-title":"Biomed. Res Int"},{"issue":"2","key":"10.1016\/j.cytogfr.2024.10.003_bib132","doi-asserted-by":"crossref","first-page":"105","DOI":"10.1016\/0009-8981(85)90219-0","article-title":"C-reactive protein as an aid in the differentiation of functional and inflammatory bowel disorders","volume":"148","author":"Shine","year":"1985","journal-title":"Clin. Chim. Acta"},{"issue":"Pt 6","key":"10.1016\/j.cytogfr.2024.10.003_bib133","doi-asserted-by":"crossref","first-page":"705","DOI":"10.1111\/j.1469-1809.2006.00272.x","article-title":"Influence of genetic variation in the C-reactive protein gene on the inflammatory response during and after acute coronary ischemia","volume":"70","author":"Suk Danik","year":"2006","journal-title":"Ann. Hum. Genet"},{"issue":"6","key":"10.1016\/j.cytogfr.2024.10.003_bib134","article-title":"Biochemical biomarkers of mucosal healing for inflammatory bowel disease in adults","volume":"10","author":"Krzystek-Korpacka","year":"2020","journal-title":"Diagn. (Basel)"},{"issue":"6","key":"10.1016\/j.cytogfr.2024.10.003_bib135","doi-asserted-by":"crossref","first-page":"802","DOI":"10.1038\/ajg.2015.120","article-title":"C-reactive protein, fecal calprotectin, and stool lactoferrin for detection of endoscopic activity in symptomatic inflammatory bowel disease patients: a systematic review and meta-analysis","volume":"110","author":"Mosli","year":"2015","journal-title":"Am. J. Gastroenterol."},{"issue":"4","key":"10.1016\/j.cytogfr.2024.10.003_bib136","doi-asserted-by":"crossref","first-page":"829","DOI":"10.1007\/s10620-013-2907-3","article-title":"Correlations of C-reactive protein levels and erythrocyte sedimentation rates with endoscopic activity indices in patients with ulcerative colitis","volume":"59","author":"Yoon","year":"2014","journal-title":"Dig. Dis. Sci."},{"issue":"5","key":"10.1016\/j.cytogfr.2024.10.003_bib137","doi-asserted-by":"crossref","first-page":"491","DOI":"10.1016\/j.clinre.2012.06.004","article-title":"Assessment of neutrophil-lymphocyte ratio in ulcerative colitis: a promising marker in predicting disease severity","volume":"36","author":"Torun","year":"2012","journal-title":"Clin. Res Hepatol. Gastroenterol."},{"issue":"4","key":"10.1016\/j.cytogfr.2024.10.003_bib138","doi-asserted-by":"crossref","first-page":"515","DOI":"10.7326\/0003-4819-104-4-515","article-title":"Jr. and M.H. Liang, The erythrocyte sedimentation rate. Guidelines for rational use.","volume":"104","author":"Sox","year":"1986","journal-title":"Ann. Intern Med"},{"issue":"11","key":"10.1016\/j.cytogfr.2024.10.003_bib139","doi-asserted-by":"crossref","first-page":"2169","DOI":"10.1002\/ibd.22936","article-title":"Serum leucine-rich alpha-2 glycoprotein is a disease activity biomarker in ulcerative colitis","volume":"18","author":"Serada","year":"2012","journal-title":"Inflamm. Bowel Dis."},{"key":"10.1016\/j.cytogfr.2024.10.003_bib140","doi-asserted-by":"crossref","first-page":"8825374","DOI":"10.1155\/2021\/8825374","article-title":"Evaluation of Serum Leucine-Rich Alpha-2 Glycoprotein as a New Inflammatory Biomarker of Inflammatory Bowel Disease","volume":"2021","author":"Yoshimura","year":"2021","journal-title":"Mediat. Inflamm."},{"issue":"8","key":"10.1016\/j.cytogfr.2024.10.003_bib141","doi-asserted-by":"crossref","first-page":"2056","DOI":"10.1002\/art.39164","article-title":"Leucine-rich \u03b12 -glycoprotein as a potential biomarker for joint inflammation during anti-interleukin-6 biologic therapy in rheumatoid arthritis","volume":"67","author":"Fujimoto","year":"2015","journal-title":"Arthritis Rheuma"},{"issue":"10","key":"10.1016\/j.cytogfr.2024.10.003_bib142","doi-asserted-by":"crossref","first-page":"2052","DOI":"10.1111\/cas.13329","article-title":"Overexpression of leucine-rich \u03b12-glycoprotein-1 is a prognostic marker and enhances tumor migration in gastric cancer","volume":"108","author":"Yamamoto","year":"2017","journal-title":"Cancer Sci."},{"issue":"1","key":"10.1016\/j.cytogfr.2024.10.003_bib143","doi-asserted-by":"crossref","first-page":"406","DOI":"10.1186\/s12885-018-4252-6","article-title":"Serum leucine-rich alpha-2-glycoprotein-1 with fucosylated triantennary N-glycan: a novel colorectal cancer marker","volume":"18","author":"Shinozaki","year":"2018","journal-title":"BMC Cancer"},{"issue":"6","key":"10.1016\/j.cytogfr.2024.10.003_bib144","doi-asserted-by":"crossref","first-page":"788","DOI":"10.1136\/gut.42.6.788","article-title":"Anti-Saccharomyces cerevisiae mannan antibodies combined with antineutrophil cytoplasmic autoantibodies in inflammatory bowel disease: prevalence and diagnostic role","volume":"42","author":"Quinton","year":"1998","journal-title":"Gut"},{"issue":"5","key":"10.1016\/j.cytogfr.2024.10.003_bib145","doi-asserted-by":"crossref","first-page":"535","DOI":"10.1038\/nm.4338","article-title":"A role for oncostatin M in inflammatory bowel disease","volume":"23","author":"Kim","year":"2017","journal-title":"Nat. Med"},{"issue":"11","key":"10.1016\/j.cytogfr.2024.10.003_bib146","doi-asserted-by":"crossref","first-page":"943","DOI":"10.1080\/14728222.2019.1677608","article-title":"Oncostatin M as a new diagnostic, prognostic and therapeutic target in inflammatory bowel disease (IBD)","volume":"23","author":"Verstockt","year":"2019","journal-title":"Expert Opin. Ther. Targets"},{"issue":"7","key":"10.1016\/j.cytogfr.2024.10.003_bib147","doi-asserted-by":"crossref","first-page":"2383","DOI":"10.1053\/j.gastro.2021.02.019","article-title":"Identification of an Anti-Integrin \u03b1v\u03b26 Autoantibody in Patients With Ulcerative Colitis","volume":"160","author":"Kuwada","year":"2021","journal-title":"Gastroenterology"},{"issue":"1","key":"10.1016\/j.cytogfr.2024.10.003_bib148","doi-asserted-by":"crossref","first-page":"241","DOI":"10.1002\/ibd.21450","article-title":"Peripheral blood microRNAs distinguish active ulcerative colitis and Crohn's disease","volume":"17","author":"Wu","year":"2011","journal-title":"Inflamm. Bowel Dis."},{"issue":"5","key":"10.1016\/j.cytogfr.2024.10.003_bib149","doi-asserted-by":"crossref","first-page":"279","DOI":"10.1038\/nri.2016.40","article-title":"MicroRNAs as regulatory elements in immune system logic","volume":"16","author":"Mehta","year":"2016","journal-title":"Nat. Rev. Immunol."},{"key":"10.1016\/j.cytogfr.2024.10.003_bib150","doi-asserted-by":"crossref","first-page":"c3369","DOI":"10.1136\/bmj.c3369","article-title":"Faecal calprotectin for screening of patients with suspected inflammatory bowel disease: diagnostic meta-analysis","volume":"341","author":"van Rheenen","year":"2010","journal-title":"Bmj"},{"issue":"33","key":"10.1016\/j.cytogfr.2024.10.003_bib151","doi-asserted-by":"crossref","first-page":"3681","DOI":"10.3748\/wjg.v24.i33.3681","article-title":"From bench to bedside: Fecal calprotectin in inflammatory bowel diseases clinical setting","volume":"24","author":"Mumolo","year":"2018","journal-title":"World J. Gastroenterol."},{"issue":"3","key":"10.1016\/j.cytogfr.2024.10.003_bib152","doi-asserted-by":"crossref","first-page":"191","DOI":"10.1016\/j.dld.2009.07.002","article-title":"Diagnostic value of faecal calprotectin in unselected outpatients referred for colonoscopy: a multicenter prospective study","volume":"42","author":"Meucci","year":"2010","journal-title":"Dig. Liver Dis."},{"issue":"8","key":"10.1016\/j.cytogfr.2024.10.003_bib153","doi-asserted-by":"crossref","first-page":"1407","DOI":"10.1097\/MIB.0000000000000057","article-title":"Meta-analysis: fecal calprotectin for assessment of inflammatory bowel disease activity","volume":"20","author":"Lin","year":"2014","journal-title":"Inflamm. Bowel Dis."},{"issue":"5","key":"10.1016\/j.cytogfr.2024.10.003_bib154","doi-asserted-by":"crossref","first-page":"1102","DOI":"10.1016\/j.cgh.2019.07.054","article-title":"Significance of conducting 2 types of fecal tests in patients with ulcerative colitis","volume":"18","author":"Naganuma","year":"2020","journal-title":"Clin. Gastroenterol. Hepatol."},{"issue":"1","key":"10.1016\/j.cytogfr.2024.10.003_bib155","doi-asserted-by":"crossref","first-page":"5","DOI":"10.5217\/ir.2016.14.1.5","article-title":"Fecal immunochemical test as a biomarker for inflammatory bowel diseases: can it rival fecal calprotectin?","volume":"14","author":"Kato","year":"2016","journal-title":"Intest Res"},{"issue":"2","key":"10.1016\/j.cytogfr.2024.10.003_bib156","doi-asserted-by":"crossref","first-page":"142","DOI":"10.5009\/gnl17013","article-title":"Fecal immunochemical test and fecal calprotectin results show different profiles in disease monitoring for ulcerative colitis","volume":"12","author":"Hiraoka","year":"2018","journal-title":"Gut Liver"},{"issue":"3","key":"10.1016\/j.cytogfr.2024.10.003_bib157","doi-asserted-by":"crossref","first-page":"201","DOI":"10.1159\/000007758","article-title":"Significant increase in prostaglandin E-main urinary metabolite by laxative administration: comparison with ulcerative colitis","volume":"61","author":"Fujiwara","year":"2000","journal-title":"Digestion"},{"issue":"1","key":"10.1016\/j.cytogfr.2024.10.003_bib158","doi-asserted-by":"crossref","first-page":"32","DOI":"10.1159\/000441665","article-title":"Prostaglandin E-major urinary metabolite as a biomarker for inflammation in ulcerative colitis: prostaglandins revisited","volume":"93","author":"Arai","year":"2016","journal-title":"Digestion"},{"issue":"6","key":"10.1016\/j.cytogfr.2024.10.003_bib159","doi-asserted-by":"crossref","first-page":"955","DOI":"10.1097\/MPG.0000000000001477","article-title":"Prostaglandin E-major urinary metabolite as a biomarker for pediatric ulcerative colitis activity","volume":"64","author":"Hagiwara","year":"2017","journal-title":"J. Pedia Gastroenterol. Nutr."},{"issue":"7","key":"10.1016\/j.cytogfr.2024.10.003_bib160","doi-asserted-by":"crossref","first-page":"1208","DOI":"10.1097\/MIB.0000000000000062","article-title":"Prostaglandin E-major urinary metabolite as a reliable surrogate marker for mucosal inflammation in ulcerative colitis","volume":"20","author":"Arai","year":"2014","journal-title":"Inflamm. Bowel Dis."},{"issue":"6","key":"10.1016\/j.cytogfr.2024.10.003_bib161","doi-asserted-by":"crossref","first-page":"978","DOI":"10.1016\/j.cgh.2013.11.005","article-title":"Endoscopic assessment and treating to target increase the likelihood of mucosal healing in patients with Crohn's disease","volume":"12","author":"Bouguen","year":"2014","journal-title":"Clin. Gastroenterol. Hepatol."},{"issue":"4","key":"10.1016\/j.cytogfr.2024.10.003_bib162","doi-asserted-by":"crossref","first-page":"586","DOI":"10.1093\/ibd\/izab239","article-title":"Neutrophil extracellular trap density increases with increasing histopathological severity of Crohn's disease","volume":"28","author":"Schroder","year":"2022","journal-title":"Inflamm. Bowel Dis."},{"key":"10.1016\/j.cytogfr.2024.10.003_bib163","doi-asserted-by":"crossref","first-page":"93","DOI":"10.1016\/j.jprot.2019.04.009","article-title":"Metaproteomics of fecal samples of Crohn's disease and Ulcerative Colitis","volume":"201","author":"Lehmann","year":"2019","journal-title":"J. Proteom."},{"issue":"1","key":"10.1016\/j.cytogfr.2024.10.003_bib164","article-title":"Fecal Myeloperoxidase as a biomarker for inflammatory bowel disease","volume":"9","author":"Hansberry","year":"2017","journal-title":"Cureus"},{"key":"10.1016\/j.cytogfr.2024.10.003_bib165","doi-asserted-by":"crossref","first-page":"61","DOI":"10.1016\/j.abb.2018.03.012","article-title":"Myeloperoxidase in the inflamed colon: a novel target for treating inflammatory bowel disease","volume":"645","author":"Chami","year":"2018","journal-title":"Arch. Biochem Biophys."},{"issue":"3","key":"10.1016\/j.cytogfr.2024.10.003_bib166","doi-asserted-by":"crossref","first-page":"677","DOI":"10.1083\/jcb.201006052","article-title":"Neutrophil elastase and myeloperoxidase regulate the formation of neutrophil extracellular traps","volume":"191","author":"Papayannopoulos","year":"2010","journal-title":"J. Cell Biol."},{"issue":"4","key":"10.1016\/j.cytogfr.2024.10.003_bib167","doi-asserted-by":"crossref","first-page":"363","DOI":"10.1159\/000075361","article-title":"Microsatellite Alterations in Free-Circulating Serum DNA in Patients with Ulcerative Colitis","volume":"21","author":"Rauh","year":"2004","journal-title":"Dig. Dis."},{"key":"10.1016\/j.cytogfr.2024.10.003_bib168","doi-asserted-by":"crossref","DOI":"10.1155\/2014\/643645","article-title":"Matrix metalloproteinase-9: its interplay with angiogenic factors in inflammatory bowel diseases","volume":"2014","author":"Matusiewicz","year":"2014","journal-title":"Dis. Markers"},{"issue":"6","key":"10.1016\/j.cytogfr.2024.10.003_bib169","doi-asserted-by":"crossref","first-page":"693","DOI":"10.1002\/ibd.20100","article-title":"Infliximab treatment influences the serological expression of matrix metalloproteinase (MMP)-2 and -9 in Crohn's disease","volume":"13","author":"Gao","year":"2007","journal-title":"Inflamm. Bowel Dis."},{"issue":"12","key":"10.1016\/j.cytogfr.2024.10.003_bib170","doi-asserted-by":"crossref","DOI":"10.1016\/j.autrev.2020.102584","article-title":"Pentraxin 3: a promising therapeutic target for autoimmune diseases","volume":"19","author":"Wu","year":"2020","journal-title":"Autoimmun. Rev."},{"issue":"1","key":"10.1016\/j.cytogfr.2024.10.003_bib171","doi-asserted-by":"crossref","first-page":"543","DOI":"10.3892\/mmr.2015.3451","article-title":"Serum pentraxin 3 is a novel marker in Crohn's disease","volume":"12","author":"Chen","year":"2015","journal-title":"Mol. Med Rep."},{"issue":"5","key":"10.1016\/j.cytogfr.2024.10.003_bib172","doi-asserted-by":"crossref","first-page":"290","DOI":"10.1111\/j.1440-1827.2011.02651.x","article-title":"Long pentraxin 3 (PTX3) expression and release by neutrophils in vitro and in ulcerative colitis","volume":"61","author":"Savchenko","year":"2011","journal-title":"Pathol. Int."},{"issue":"12","key":"10.1016\/j.cytogfr.2024.10.003_bib173","doi-asserted-by":"crossref","first-page":"2106","DOI":"10.3748\/wjg.v23.i12.2106","article-title":"Regulation of intestinal permeability: The role of proteases","volume":"23","author":"Van Spaendonk","year":"2017","journal-title":"World J. Gastroenterol."},{"issue":"5","key":"10.1016\/j.cytogfr.2024.10.003_bib174","doi-asserted-by":"crossref","first-page":"1200","DOI":"10.1007\/s00125-010-2042-z","article-title":"Leucocytes are a major source of circulating nicotinamide phosphoribosyltransferase (NAMPT)\/pre-B cell colony (PBEF)\/visfatin linking obesity and inflammation in humans","volume":"54","author":"Friebe","year":"2011","journal-title":"Diabetologia"},{"issue":"1","key":"10.1016\/j.cytogfr.2024.10.003_bib175","doi-asserted-by":"crossref","DOI":"10.3390\/ijms20010166","article-title":"Oversecretion and overexpression of nicotinamide phosphoribosyltransferase\/Pre-B colony-enhancing factor\/visfatin in inflammatory bowel disease reflects the disease activity, severity of inflammatory response and hypoxia","volume":"20","author":"Neubauer","year":"2019","journal-title":"Int J. Mol. Sci."},{"issue":"22","key":"10.1016\/j.cytogfr.2024.10.003_bib176","doi-asserted-by":"crossref","first-page":"6912","DOI":"10.3748\/wjg.v20.i22.6912","article-title":"Serum adipokines in inflammatory bowel disease","volume":"20","author":"Waluga","year":"2014","journal-title":"World J. Gastroenterol."},{"key":"10.1016\/j.cytogfr.2024.10.003_bib177","doi-asserted-by":"crossref","first-page":"627","DOI":"10.3389\/fmicb.2014.00627","article-title":"Triggering receptor expressed on myeloid cells-1 (TREM-1): a new player in antiviral immunity?","volume":"5","author":"Roe","year":"2014","journal-title":"Front Microbiol"},{"issue":"4","key":"10.1016\/j.cytogfr.2024.10.003_bib178","doi-asserted-by":"crossref","first-page":"604","DOI":"10.1136\/gutjnl-2017-315494","article-title":"Cell-centred meta-analysis reveals baseline predictors of anti-TNF\u03b1 non-response in biopsy and blood of patients with IBD","volume":"68","author":"Gaujoux","year":"2019","journal-title":"Gut"},{"issue":"8","key":"10.1016\/j.cytogfr.2024.10.003_bib179","doi-asserted-by":"crossref","first-page":"1531","DOI":"10.1136\/gutjnl-2018-316845","article-title":"TREM-1, the ideal predictive biomarker for endoscopic healing in anti-TNF-treated Crohn's disease patients?","volume":"68","author":"Verstockt","year":"2019","journal-title":"Gut"},{"key":"10.1016\/j.cytogfr.2024.10.003_bib180","doi-asserted-by":"crossref","first-page":"733","DOI":"10.1016\/j.ebiom.2019.01.027","article-title":"Low TREM1 expression in whole blood predicts anti-TNF response in inflammatory bowel disease","volume":"40","author":"Verstockt","year":"2019","journal-title":"EBioMedicine"},{"issue":"9","key":"10.1016\/j.cytogfr.2024.10.003_bib181","doi-asserted-by":"crossref","first-page":"1447","DOI":"10.1093\/ecco-jcc\/jjac047","article-title":"A Specific Calprotectin Neo-epitope [CPa9-HNE] in serum from inflammatory bowel disease patients is associated with neutrophil activity and endoscopic severity","volume":"16","author":"Mortensen","year":"2022","journal-title":"J. Crohns Colitis"},{"issue":"1","key":"10.1016\/j.cytogfr.2024.10.003_bib182","doi-asserted-by":"crossref","DOI":"10.1016\/j.celrep.2020.107857","article-title":"GM-CSF Calibrates macrophage defense and wound healing programs during intestinal infection and inflammation","volume":"32","author":"Castro-Dopico","year":"2020","journal-title":"Cell Rep."},{"issue":"1","key":"10.1016\/j.cytogfr.2024.10.003_bib183","doi-asserted-by":"crossref","first-page":"12","DOI":"10.1186\/s40348-015-0024-4","article-title":"GM-CSF and the role of myeloid regulatory cells in the pathogenesis and treatment of Crohn's disease","volume":"2","author":"D\u00e4britz","year":"2015","journal-title":"Mol. Cell Pedia"},{"issue":"3","key":"10.1016\/j.cytogfr.2024.10.003_bib184","doi-asserted-by":"crossref","first-page":"231","DOI":"10.1016\/j.autrev.2014.11.004","article-title":"Systematic review: new serological markers (anti-glycan, anti-GP2, anti-GM-CSF Ab) in the prediction of IBD patient outcomes","volume":"14","author":"Bonneau","year":"2015","journal-title":"Autoimmun. Rev."}],"container-title":["Cytokine &amp; Growth Factor Reviews"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1359610124000820?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1359610124000820?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2026,5,12]],"date-time":"2026-05-12T16:01:50Z","timestamp":1778601710000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1359610124000820"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2024,12]]},"references-count":184,"alternative-id":["S1359610124000820"],"URL":"https:\/\/doi.org\/10.1016\/j.cytogfr.2024.10.003","relation":{},"ISSN":["1359-6101"],"issn-type":[{"value":"1359-6101","type":"print"}],"subject":[],"published":{"date-parts":[[2024,12]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Unraveling the intricacies of neutrophil extracellular traps in inflammatory bowel disease: Pathways, biomarkers, and promising therapies","name":"articletitle","label":"Article Title"},{"value":"Cytokine & Growth Factor Reviews","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.cytogfr.2024.10.003","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2024 The Authors. Published by Elsevier Ltd.","name":"copyright","label":"Copyright"}]}}